ERBB2 and neoplasm: Of note, the tumor regression observed in mice treated with CTX and Sl-IFN, only transiently induced by CTX and Sl-mock, persisted for several weeks, thus suggesting the elicitation of an effective and long-lasting antitumor immune response overcoming the pro-carcinogenic signal of Her2 in tumor cells and immune tolerance.